Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Zactran
1. 145435-72-9
2. Ml-1709460
3. Ml-1,709,460
4. Ml-460
5. Ze856183s0
6. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-11-(((2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-(((2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-7-propyl-1-oxa-7-azacyclopentadecan-15-one
7. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-11-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-7-propyl-1-oxa-7-azacyclopentadecan-15-one
8. Gamithromycin [usan:inn]
9. Unii-ze856183s0
10. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-11-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8
11. Gamithromycin [mi]
12. Gamithromycin [inn]
13. Gamithromycin [usan]
14. Chembl2107342
15. Dtxsid90904260
16. Gamithromycin [green Book]
17. Ex-a1349
18. Mfcd09954125
19. S5328
20. Zinc169292837
21. Cs-7858
22. Db11416
23. Ds-4441
24. Gamithromycin 100 Microg/ml In Methanol
25. Ac-32611
26. Gamithromycin [ema Epar Veterinary]
27. Hy-108365
28. C72760
29. 435g729
30. A884620
31. J-008105
32. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-13-((2,6-dideoxy-3-c-methyl-3-o-methyl-.alpha.-l-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-((3,4,6-trideoxy-3-(dimethylamino)-.beta.-d-xylo-hexopyranosyl)oxy)-1-oxa-7-azacyclopentadecan-15-one
33. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-13-[(2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-ribo-hexopyranosyl)
34. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-13-[(2,6-dideoxy-3-cmethyl-3-o-methyl-a-l-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-d-xylo-hexopyranosyl]oxy]-1-oxa-7-azacyclopentadecan-15-one
35. 1-oxa-7-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-c-methyl-3-o-methyl-.alpha.-l-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-((3,4,6-trideoxy-3-(dimethylamino)-.beta.-d-xylo-hexopyranosyl)oxy)-, (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-
36. 1-oxa-7-azacyclopentadecan-15-one,13-[(2,6-dideoxy-3-c-methyl-3-o-methyl-a-l-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-d-xylo-hexopyranosyl]oxy]-,[2r-(2r*,3s*,4r*,5s*,8r*,10r*,11r*,12s*,13s*,14r*)]-
Molecular Weight | 777.0 g/mol |
---|---|
Molecular Formula | C40H76N2O12 |
XLogP3 | 4.9 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 9 |
Exact Mass | 776.53982586 g/mol |
Monoisotopic Mass | 776.53982586 g/mol |
Topological Polar Surface Area | 180 Ų |
Heavy Atom Count | 54 |
Formal Charge | 0 |
Complexity | 1180 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 18 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
* Cattle:
Treatment and metaphylaxis of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. The presence of the disease in the herd should be established before metaphylactic use.
* Pigs:
Treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Bordetella bronchiseptica.
* Sheep:
Treatment of infectious pododermatitis (foot rot) associated with virulent Dichelobacter nodosus and Fusobacterium necrophorum requiring systemic treatment.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
QJ01FA95
Related Excipient Companies
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
74
PharmaCompass offers a list of Gamithromycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gamithromycin manufacturer or Gamithromycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gamithromycin manufacturer or Gamithromycin supplier.
PharmaCompass also assists you with knowing the Gamithromycin API Price utilized in the formulation of products. Gamithromycin API Price is not always fixed or binding as the Gamithromycin Price is obtained through a variety of data sources. The Gamithromycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ZACTRAN manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ZACTRAN, including repackagers and relabelers. The FDA regulates ZACTRAN manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ZACTRAN API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ZACTRAN manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ZACTRAN supplier is an individual or a company that provides ZACTRAN active pharmaceutical ingredient (API) or ZACTRAN finished formulations upon request. The ZACTRAN suppliers may include ZACTRAN API manufacturers, exporters, distributors and traders.
click here to find a list of ZACTRAN suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
ZACTRAN Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ZACTRAN GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ZACTRAN GMP manufacturer or ZACTRAN GMP API supplier for your needs.
A ZACTRAN CoA (Certificate of Analysis) is a formal document that attests to ZACTRAN's compliance with ZACTRAN specifications and serves as a tool for batch-level quality control.
ZACTRAN CoA mostly includes findings from lab analyses of a specific batch. For each ZACTRAN CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ZACTRAN may be tested according to a variety of international standards, such as European Pharmacopoeia (ZACTRAN EP), ZACTRAN JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ZACTRAN USP).